Haemophilia Trial, Recruiting (NCT05981274)

Haemophilia Trial, Recruiting NCT05981274 Sponsor: Tri-Service General Hospital (TSGH) Condition: Haemophilia

Printed from Voxsanity (voxsanity.com.au) — NCT05981274 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Haemophilia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any age who have been diagnosed with severe hemophilia A
People who have moderate hemophilia A and have developed joint damage as a result of their condition
People who are currently taking a specific clotting factor treatment called rFVIIIFc on a regular preventative schedule, and who also have at least one year of medical records showing they previously took a standard version of this type of treatment regularly
People who are willing and able to attend appointments for joint and bone check-ups

Who may not be able to join:

People who are currently taking part in another clinical trial that involves a treatment or intervention
People who currently have inhibitors (antibodies that block the effectiveness of clotting factor treatment)
People who have a history of a serious neurological condition, such as stroke, Parkinson's disease, or nerve damage (confirm with trial site)
People who have a history of a serious psychiatric condition, such as schizophrenia or bipolar disorder
People whose vision or hearing is significantly impaired

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (+886)2-87923311

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05981274

Sponsor: Tri-Service General Hospital (TSGH)

Phase: Not Applicable

Status: Recruiting

Condition: Haemophilia

Trial contact: (+886)2-87923311

More information: https://clinicaltrials.gov/study/NCT05981274

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any age who have been diagnosed with severe hemophilia A
People who have moderate hemophilia A and have developed joint damage as a result of their condition
People who are currently taking a specific clotting factor treatment called rFVIIIFc on a regular preventative schedule, and who also have at least one year of medical records showing they previously took a standard version of this type of treatment regularly
People who are willing and able to attend appointments for joint and bone check-ups

Who may not be able to join:

People who are currently taking part in another clinical trial that involves a treatment or intervention
People who currently have inhibitors (antibodies that block the effectiveness of clotting factor treatment)
People who have a history of a serious neurological condition, such as stroke, Parkinson's disease, or nerve damage (confirm with trial site)
People who have a history of a serious psychiatric condition, such as schizophrenia or bipolar disorder
People whose vision or hearing is significantly impaired

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tri-Service General Hospital (TSGH)

Registry

ClinicalTrials.gov

Start date

14 July 2023

Est. completion

31 December 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Systematic joint and bone health assessments before and after enrollment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov